RNVA (Rennova Health) Days Payable: 537.02 (As of Dec. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

RNVA Rennova Health Inc RNVA
12 GF Score
Price $0.00
View Full Analysis

What is Rennova Health Days Payable?

Rennova Health RNVA -99.00% 12 Days Payable is 537.02 as of Dec. 2023. GuruFocus rates RNVA with a GF Score™ of 12/100.

Rennova Health's average Accounts Payable for the three months ended in Dec. 2023 was $12.25 Mil. Rennova Health's Cost of Goods Sold for the three months ended in Dec. 2023 was $2.08 Mil. Hence, Rennova Health's Days Payable for the three months ended in Dec. 2023 was 537.02.

The historical rank and industry rank for Rennova Health's Days Payable or its related term are showing as below:

RNVA's Days Payable is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 64.64
* Ranked among companies with meaningful Days Payable only.

Rennova Health's Days Payable declined from Dec. 2022 (538.55) to Dec. 2023 (537.02). It may suggest that Rennova Health accelerated paying its suppliers.

Rennova Health Days Payable Historical Data

* Premium members only.

The historical data trend for Rennova Health's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rennova Health Days Payable Chart

Rennova Health Annual Data
Trend Mar14 Mar15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 259.25 419.15 909.81 629.34 568.00

Rennova Health Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 538.55 565.33 616.09 634.88 537.02

RNVA vs ISPC, CNTGF, NSTM: Days Payable Comparison

For the Diagnostics & Research subindustry, Rennova Health's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rennova Health Days Payable vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Rennova Health's Days Payable distribution charts can be found below:

* The bar in red indicates where Rennova Health's Days Payable falls into.


RNVA
12GF Score
Rennova Health Inc RNVA
Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rennova Health Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Rennova Health's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

Days Payable (A: Dec. 2023 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2022 ) + Accounts Payable (A: Dec. 2023 )) / count ) / Cost of Goods Sold (A: Dec. 2023 )*Days in Period
=( (11.204 + 12.372) / 2 ) / 7.575*365
=11.788 / 7.575*365
=568.00

Rennova Health's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

Days Payable (Q: Dec. 2023 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Sep. 2023 ) + Accounts Payable (Q: Dec. 2023 )) / count ) / Cost of Goods Sold (Q: Dec. 2023 )*Days in Period
=( (12.122 + 12.372) / 2 ) / 2.081*365 / 4
=12.247 / 2.081*365 / 4
=537.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 537.02 mean?
Rennova Health (RNVA) has a Days Payable of 537.02 as of Dec. 2023. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Rennova Health and its competitors.
Is Rennova Health's Days Payable too high?
Rennova Health's current Days Payable is 537.02. The Medical Diagnostics & Research industry median Days Payable is 64.64. Rennova Health's value of 537.02 is 730.8% above this industry median. Overall, Rennova Health has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Rennova Health's Days Payable compare to ISPC and CNTGF?
Rennova Health's Days Payable of 537.02 can be compared against companies in the Medical Diagnostics & Research industry. The industry median Days Payable is 64.64. Rennova Health's value of 537.02 is 730.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Diagnostics & Research company?
The median Days Payable among Medical Diagnostics & Research companies is 64.64, based on 190 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rennova Health's current Days Payable of 537.02 is 730.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Rennova Health and its competitors. For the Medical Diagnostics & Research industry, the median Days Payable is 64.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rennova Health's current Days Payable is 537.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rennova Health stock overvalued right now?
Rennova Health (RNVA) has a current Days Payable of 537.02. The current Days Payable is 537.02 and 730.8% above the Medical Diagnostics & Research industry median of 64.64. Rennova Health's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Rennova Health (RNVA), the current Days Payable is 537.02 as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Rennova Health Business Description

Address 477 S. Rosemary Avenue, Suite 800, West Palm Beach, FL, USA, 33401
Rennova Health Inc is a vertically integrated provider of healthcare-related products and services. The company operates through a single business segment namely the Hospital operations segment reflects the purchase of the hospital assets. Geographically, the activities are carried out throughout the region of the United States.
12GF Score

Get the complete analysis for RNVA

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price